Andere Sprachen Willow Biosciences Inc. OTC Markets

Aktien

A2PK2F

CA97111B4047

CANSF

Verzögert OTC Markets Andere Börsenplätze 19:08:30 06.06.2024			% 5 Tage	% 1. Jan.
0.076 ^USD	-7.54%		+1.33%	+8.73%

30.05.	Willow Biosciences Inc. kündigt Multi-Produkt Entwicklungs- und Lizenzierungspartnerschaft mit Laurus Labs an	CI
13.05.	Willow Biosciences Inc. gibt Gewinnprognose für das Geschäftsjahr 2024 ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	03.06.
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	03.06.
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	03.06.
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding	03.06.
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	30.05.
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab	30.05.
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	30.05.
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	30.05.
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	13.05.
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024	13.05.
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
Willow Biosciences Narrows 2023 Loss YOY	01.04.
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	29.03.
Willow Biosciences Announces Second Strategic Investment From Kalsec	01.03.
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient	21.02.
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.	20.02.
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	31.01.
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	31.01.
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	31.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Willow Biosciences Inc. OTC Markets

Aktien

A2PK2F

CA97111B4047

CANSF

Andere Sprachen

Filter